ATE479430T1 - Verwendung von retinoid-typ verbindungen als antibakterielle mittel gegen staphylococcus aureus - Google Patents

Verwendung von retinoid-typ verbindungen als antibakterielle mittel gegen staphylococcus aureus

Info

Publication number
ATE479430T1
ATE479430T1 AT01903998T AT01903998T ATE479430T1 AT E479430 T1 ATE479430 T1 AT E479430T1 AT 01903998 T AT01903998 T AT 01903998T AT 01903998 T AT01903998 T AT 01903998T AT E479430 T1 ATE479430 T1 AT E479430T1
Authority
AT
Austria
Prior art keywords
staphylococcus aureus
retinoid
antibacterial agent
type compounds
agent against
Prior art date
Application number
AT01903998T
Other languages
English (en)
Inventor
Johannes Voegel
Marie-Therese Cavey
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Application granted granted Critical
Publication of ATE479430T1 publication Critical patent/ATE479430T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01903998T 2000-01-31 2001-01-30 Verwendung von retinoid-typ verbindungen als antibakterielle mittel gegen staphylococcus aureus ATE479430T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0001206A FR2804323B1 (fr) 2000-01-31 2000-01-31 Utilisation de composes de type retinoides en tant qu'agents anti-bacteriens
PCT/FR2001/000280 WO2001056554A2 (fr) 2000-01-31 2001-01-30 Utilisation de composes de type retinoides en tant qu'agents anti-bacteriens

Publications (1)

Publication Number Publication Date
ATE479430T1 true ATE479430T1 (de) 2010-09-15

Family

ID=8846500

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01903998T ATE479430T1 (de) 2000-01-31 2001-01-30 Verwendung von retinoid-typ verbindungen als antibakterielle mittel gegen staphylococcus aureus

Country Status (15)

Country Link
US (1) US6858647B2 (de)
EP (1) EP1255543B1 (de)
JP (1) JP2003521510A (de)
AT (1) ATE479430T1 (de)
AU (1) AU777629B2 (de)
BR (1) BR0108115A (de)
CA (1) CA2399087C (de)
DE (1) DE60142958D1 (de)
ES (1) ES2351595T3 (de)
FR (1) FR2804323B1 (de)
MX (1) MXPA02007371A (de)
NO (1) NO331260B1 (de)
NZ (1) NZ520316A (de)
WO (1) WO2001056554A2 (de)
ZA (1) ZA200205738B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767525B1 (fr) * 1997-08-21 1999-11-12 Cird Galderma Derives biphenyliques substitues par un radical aromatique ou heteroaromatique et compositions pharmaceutiques et cosmetiques les contenant
CN100348569C (zh) * 2001-11-30 2007-11-14 伯哈姆学院 癌细胞中编程性细胞死亡的诱导
EP1660503A1 (de) * 2003-08-29 2006-05-31 Pfizer Inc. Naphthalincarboxamide und derivate als neue anti-angiogene mittel
FR2862870A1 (fr) * 2003-12-01 2005-06-03 Galderma Res & Dev Utilisation d'activateurs de recepteurs ppar en cosmetique et dermatologie.
GB0401876D0 (en) 2004-01-28 2004-03-03 Vereniging Het Nl Kanker I New use for cancer antigen
JP4736463B2 (ja) * 2004-02-27 2011-07-27 住友ベークライト株式会社 縮合系高分子原料およびそれらの合成法
EP3181132A1 (de) * 2007-01-15 2017-06-21 Chongxi Yu Positiv geladene wasserlösliche prodrugs von retinoiden und retinoidähnlichen verbindungen mit sehr hohen hautpenetrationsraten
US11707442B2 (en) 2015-09-25 2023-07-25 The General Hospital Corporation Antibacterial and antifungal compounds
WO2018213609A1 (en) * 2017-05-17 2018-11-22 Ausubel Frederick M Antibiotic compounds
IT201900003343A1 (it) 2019-03-07 2020-09-07 Special Product’S Line S P A Derivati fenolici per uso come antimicrobici, antibatterici, battericidi
RU2714932C1 (ru) * 2019-09-26 2020-02-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский национальный исследовательский государственный университет имени Н.Г. Чернышевского" Средство, обладающее цитотоксической активностью
IT202000029906A1 (it) 2020-12-04 2022-06-04 Special Product’S Line S P A Derivati fenolici per uso come antimicrobici, antibatterici, battericidi.
IT202000029912A1 (it) 2020-12-04 2022-06-04 Special Product’S Line S P A Derivati fenolici per uso come antimicrobici, antibatterici, battericidi
IT202000029882A1 (it) 2020-12-04 2022-06-04 Special Product’S Line S P A Derivati fenolici per uso come antimicrobici, antibatterici, battericidi
CN115414360A (zh) * 2022-08-30 2022-12-02 上海交通大学医学院附属仁济医院 全反式维甲酸联合抗生素在治疗假体周围感染中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85849A1 (fr) * 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
FR2614618B1 (fr) * 1987-04-30 1989-07-07 Cird Derives heterocycliques polycycliques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire
MY106263A (en) * 1989-01-19 1995-04-29 Ortho Pharma Corp Method for the treatment or prevention of intrinsically aged skin with retinoids
US5188817A (en) * 1989-03-27 1993-02-23 Julius Ozick Method of treatment for periodontitis
EP0625045A4 (de) * 1992-02-07 1995-01-18 Albert M Kligman Verfahren zur behandlung von entzündlichen dermatosen.
FR2713640B1 (fr) * 1993-12-15 1996-01-05 Cird Galderma Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
FR2719044B1 (fr) * 1994-04-26 1996-05-31 Cird Galderma Nouveaux composés bi-aromatiques acétylénés à groupement adamantyle, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
FR2733684B1 (fr) * 1995-05-03 1997-05-30 Cird Galderma Utilisation de retinoides dans une composition cosmetique ou pour la fabrication d'une composition pharmaceutique
FR2736548B1 (fr) * 1995-07-10 1997-10-03 Fabre Pierre Dermo Cosmetique Utilisation d'un retinoide pour la preparation d'un medicament antibacterien et methode de traitement cosmetique
FR2738745B1 (fr) * 1995-09-15 1997-10-24 Cird Galderma Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide, et leurs utilisations
FR2755011B1 (fr) * 1996-10-31 1998-11-20 Cird Galderma Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles et/ou les dommages aigus induits par les rayonnements u.v.
FR2759292B1 (fr) * 1997-02-10 2000-08-11 Cird Galderma Utilisation de retinoides en tant qu'agents induisant la pigmentation
FR2763588B1 (fr) * 1997-05-23 1999-07-09 Cird Galderma Composes triaromatiques, compositions les contenant et utilisations
FR2767525B1 (fr) * 1997-08-21 1999-11-12 Cird Galderma Derives biphenyliques substitues par un radical aromatique ou heteroaromatique et compositions pharmaceutiques et cosmetiques les contenant
FR2761600B1 (fr) * 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
US6017938A (en) * 1998-07-28 2000-01-25 Bershad; Susan Short contact treatment for acne
FR2787322B1 (fr) * 1998-12-18 2002-10-18 Galderma Res & Dev Emulsion huile-dans-eau comprenant un agent actif micronise et un systeme emulsionnant approprie

Also Published As

Publication number Publication date
AU3193601A (en) 2001-08-14
EP1255543A2 (de) 2002-11-13
FR2804323B1 (fr) 2006-07-07
AU777629B2 (en) 2004-10-21
MXPA02007371A (es) 2004-07-30
DE60142958D1 (de) 2010-10-14
CA2399087A1 (fr) 2001-08-09
US20030055110A1 (en) 2003-03-20
NO20023630L (no) 2002-09-30
FR2804323A1 (fr) 2001-08-03
ES2351595T3 (es) 2011-02-08
NZ520316A (en) 2004-05-28
EP1255543B1 (de) 2010-09-01
CA2399087C (fr) 2009-12-15
NO20023630D0 (no) 2002-07-30
WO2001056554A2 (fr) 2001-08-09
ZA200205738B (en) 2003-03-27
NO331260B1 (no) 2011-11-14
BR0108115A (pt) 2002-10-22
JP2003521510A (ja) 2003-07-15
US6858647B2 (en) 2005-02-22
WO2001056554A3 (fr) 2001-12-20

Similar Documents

Publication Publication Date Title
ATE479430T1 (de) Verwendung von retinoid-typ verbindungen als antibakterielle mittel gegen staphylococcus aureus
DE50012238D1 (de) Desinfizierendes waschen empfindlicher textilien mit persäuren
BR0312479A (pt) Composição de tratamento dos cabelos e/ou couro cabeludo, método de tratamento de caspa e uso de óleo de manjericão
ATE372985T1 (de) N-alkyl-4-methylenamino-3-hydroxy-2-pyridone verwendbar als antimikrobielle mittel
DE60131138D1 (de) Antibakterielle mittel
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
ATE516022T1 (de) Antimikrobielle zusammensetzungen und anwendungsverfahren dafür
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
ATE532508T1 (de) Kombination von alkandiol und hydroxysäure zur behandlung von akne
DE60012610D1 (de) Selektive antibakterielle Zusammensetzungen
BRPI0411534A (pt) derivados de lincomicina com atividade antimicrobiana
WO2005054234A3 (en) Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy
HK1099316A1 (en) Methods for inducing autolysis in infectious bacteria
EA200500353A1 (ru) Производные линкомицина, обладающие антибактериальной активностью
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
ATE353642T1 (de) Verwendung von hypoestoxiden als antiparasitäre mittel
ATE517108T1 (de) 9-(1',5'-dimethyl-1'-vinyl-4'-hexenyl)-4-hydrox - 7h-furoä3,2-güä1übenzopyran-7-on als antibakterielles mittel
ECSP993109A (es) Nuevos agentes antibacterianos de isoxazolinona
PT1233748E (pt) Associacao de retinal e aldeidos com actividade antifungica
BRPI0411537A (pt) derivados de lincomicina que possuem atividade antibacteriana
SE0303364D0 (sv) New device and method for prevention of nocosomial infections
DE602004020985D1 (de) Impfstoffzusammensetzung, eisenphosphat als adjuvans enthaltend

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties